Compounds > methylprednisolone

methylprednisolone and Dysmyelopoietic Syndromes

methylprednisolone has been researched along with Dysmyelopoietic Syndromes in 53 studies

Research

Studies (53)

TimeframeStudies, this research(%)All Research%
pre-19902 (3.77)18.7374
1990's14 (26.42)18.2507
2000's21 (39.62)29.6817
2010's15 (28.30)24.3611
2020's1 (1.89)2.80

Authors

AuthorsStudies
Billick, M; Liu, J; Monsour, D; Wang, X1
Bordelon, J; Ho, J; James, A; Karunamurthy, A; Kazlouskaya, V; Khosravi, H; Mizes, A; Patton, T1
Liu, T; Shen, K; Xiang, B1
Cai, JF; Chen, Y; Guan, JL; Hua, YQ; Ma, HF; Shen, Y; Zou, J1
Cho, BS; Cho, SG; Eom, KS; Kim, DW; Kim, HJ; Kim, YJ; Lee, JW; Lee, S; Lee, SE; Min, CK; Min, GJ; Park, S; Park, SS; Yoon, JH1
Hayashi, Y; Hino, M; Inaba, A; Inoue, A; Koh, H; Nakamae, H; Nakane, T; Nakashima, Y; Nanno, S; Nishimoto, M; Okamura, H; Shimono, T1
Imokawa, S; Kageyama, H; Nishimoto, K; Sagisaka, S; Sato, J; Suda, T; Suzuki, S; Uto, T; Yasuda, K1
Alamani, M; Kaltsas, G; Kampolis, CF; Moschovi, M; Tzelepis, E; Vlachadami, I1
Jain, K; Mudaliar, S; Swami, A1
Gojo, I; Malla, M; Newman, M1
Hangaishi, A; Ichikawa, M; Imai, Y; Kataoka, K; Kurokawa, M; Takahashi, T1
Erdel, M; Fiegl, M; Kilga-Nogler, S; Köck, L; Schennach, H; Sun, WL; Walder, A1
Nagai, T; Omori, K; Tabata, C; Tabata, R1
Sbicca, JA; Schmit, JM; Shugarman, IL; Wirk, B1
Borthakur, G; Brandt, M; Estrov, Z; Faderl, S; Garcia-Manero, G; Huang, X; Jabbour, E; Kadia, TM; Kantarjian, HM; Koller, C; Pierce, S; Ravandi, F; York, S1
Hamada, J; Hamaguchi, Y; Hayashi, Y; Nakada, M; Shimizu, Y; Sugimori, N; Watanabe, T1
Cabrera-Pérez, R; Conejo-Mir, J; Lorente-Lavirgen, AI; Luque-Márquez, R; Pulpillo-Ruiz, A1
Frickhofen, N; Heimpel, H; Kaltwasser, JP; Schrezenmeier, H1
Asano, T; Cai, LZ; Hayakawa, J; Maeda, M; Migita, M; Orimoto, M; Ueda, T1
Chau, T; Dai, MS; Lin, SH; Yang, SS1
Fujimori, Y; Hara, H; Kakishita, E; Mori, A; Okada, M; Okamoto, T; Takatsuka, H; Wakae, T1
Hara, T; Kasahara, S; Moriwaki, H; Sawada, M; Tsurumi, H; Yamada, T1
Estey, EH; Giles, FJ; Kantarjian, HM; Kurzrock, R; O'Brien, SA; Tsimberidou, AM; Yazji, S1
Ikegaya, S; Ishida, K; Iwashima, Y; Kawai, Y; Kumakiri, M; Ueda, T; Wakahara, M; Yamauchi, T1
Bourantas, KL; Chaidos, A; Christou, L; Gouva, M; Kapsali, E; Panteli, K; Tsiara, SN1
Fujimi, A; Matsunaga, T; Murase, K; Niitsu, Y; Takahira, N; Takeuchi, N; Takimoto, R; Terui, T1
Urabe, A1
Aessopos, A; Deftereos, S; Farmakis, D; Floudas, H; Giakoumi, X; Grapsa, A; Polonifi, A; Polymeropoulos, E1
Auerbach, AD; Defor, TE; Macmillan, ML; Slungaard, A; Tan, PL; Wagner, JE1
Champlin, R; Couriel, DM; de Lima, M; Giralt, S; Lee, HJ; Massey, P; Neumann, J; Oran, B; Saliba, RM; Shin, K1
Akiyama, H; Kamata, N; Kisida, S; Ohashi, K; Ohta, K; Sakai, M; Sakamaki, H; Yamashita, T1
Fujioka, T; Hasei, H; Ikegame, K; Inoue, T; Kaida, K; Kawakami, M; Kawase, I; Kim, EH; Masuda, T; Ogawa, H; Taniguchi, Y; Yoshihara, S1
Katayama, N; Masuya, M; Ohishi, K; Sekine, T; Suzuki, K1
Hueser, CN; Patel, AJ1
Hino, K; Nakamaki, T1
Baxter-Lowe, LA; Bunin, N; Camitta, B; Casper, J; Garbrecht, F; Hunter, J; Lawton, C; Murray, K; Pietryga, D; Truitt, R1
Bowden, R; Longton, G; Pepe, M; Sayer, HG; Storb, R1
Akashi, K; Eto, T; Gondo, H; Harada, M; Hayashi, S; Nagafuji, K; Takamatsu, Y; Taniguchi, S; Teshima, T; Yamasaki, K1
Ala-Harja, K; Almqvist, A; Elonen, E; Hallman, H; Hänninen, A; Ilvonen, M; Isomaa, B; Järvenpää, E; Jouppila, J; Palva, IP1
Anasetti, C; Anderson, JE; Appelbaum, FR; Bensinger, WI; Bryant, E; Buckner, CD; Chauncey, T; Clift, RA; Gooley, T; Schoch, G1
Imai, Y; Kikuchi, M; Ohsaka, A; Sugahara, Y1
Fukuoka, T; Imai, Y; Nakatani, A; Ohsaka, A; Takahashi, A1
Cetin, M; Güler, E; Hiçsönmez, G; Mufti, GJ; Ozbek, N; Sayli, T; Tuncer, AM1
Avvisati, G; Jaalouk, G; Latagliata, R; Malagnino, F; Mecarocci, S; Pacchiarotti, A; Pulsoni, A1
Anasetti, C; Appelbaum, FR; Boeckh, M; Chauncey, TR; Deeg, HJ; Doney, K; Flowers, M; Leisenring, W; Lin, D; Martin, P; Nash, R; Schoch, G; Storb, R; Sullivan, KM; Witherspoon, RP1
Bertz, H; Finke, J; Mertelsmann, R; Potthoff, K1
Hiçsönmez, G; Tuncer, AM; Yenicesu, I1
Endo, T; Matsuki, A; Munakata, A; Takami, H; Tamai, Y1
Hiramatsu, K; Mito, K; Nagai, H; Nasu, M; Yamagata, E; Yamakami, Y; Yamasaki, T1
Aktaş, D; Cetin, M; Hiçsönmez, G; Koç, A; Olcay, L; Tunçbilek, E; Tuncer, M; Yenicesu, I1
Andersson, BS; Brunner, LJ; Deisseroth, AB; Dimopoulos, MA; Huan, SD; Spencer, V; Spitzer, G; Wallerstein, RO; Woo, SY; Yau, JC1
Appelbaum, FR; Buckner, CD; Deeg, HJ; Doney, K; McGuffin, R; Storb, R; Sullivan, KM; Thomas, ED; Witherspoon, R1
Anonsen, CK; Petroff, MA; Schwarz, MB1

Reviews

4 review(s) available for methylprednisolone and Dysmyelopoietic Syndromes

ArticleYear
[Case of organizing pneumonia associated with sweet's syndrome].
    Arerugi = [Allergy], 2014, Volume: 63, Issue:7

    Topics: Aged; Cryptogenic Organizing Pneumonia; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Myelodysplastic Syndromes; Neutrophils; Prednisolone; Pulse Therapy, Drug; Skin; Sweet Syndrome; Tacrolimus; Treatment Outcome

2014
Cryptogenic organizing pneumonia in Sweet's syndrome: case report and review of the literature.
    The clinical respiratory journal, 2016, Volume: 10, Issue:2

    Topics: Administration, Intravenous; Adolescent; Adrenal Cortex Hormones; Cryptogenic Organizing Pneumonia; Hodgkin Disease; Humans; Male; Methylprednisolone; Myelodysplastic Syndromes; Sweet Syndrome; Treatment Outcome

2016
[Myelodysplastic syndrome].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:3

    Topics: Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Antilymphocyte Serum; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methylprednisolone; Myelodysplastic Syndromes; Prognosis; World Health Organization

2005
[A case of pulmonary manifestation associated with myelodysplastic syndrome].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2000, Volume: 38, Issue:11

    Topics: Aged; Drug Therapy, Combination; Female; Humans; Lung; Lung Diseases, Interstitial; Methylprednisolone; Myelodysplastic Syndromes; Necrosis; Neutrophil Infiltration; Prednisolone; Relapsing Fever; Treatment Outcome

2000

Trials

9 trial(s) available for methylprednisolone and Dysmyelopoietic Syndromes

ArticleYear
Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome.
    British journal of haematology, 2012, Volume: 157, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Survival Analysis; Treatment Outcome; Young Adult

2012
Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia.
    Blood, 2003, Feb-15, Volume: 101, Issue:4

    Topics: Anemia, Aplastic; Antilymphocyte Serum; Blood Cell Count; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Follow-Up Studies; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Kinetics; Leukemia; Methylprednisolone; Myelodysplastic Syndromes; Neoplasms; Recurrence; Remission Induction; Salvage Therapy; Survival Rate

2003
Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes.
    Leukemia, 2003, Volume: 17, Issue:11

    Topics: Adult; Aged; Antilymphocyte Serum; Blood Transfusion; Cyclosporine; Female; Hematocrit; Humans; Immunosuppressive Agents; Karyotyping; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Platelet Count; Treatment Outcome

2003
Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2006, Volume: 12, Issue:10

    Topics: Adult; Antilymphocyte Serum; Bone Marrow; Busulfan; CD4 Lymphocyte Count; Combined Modality Therapy; Cytokines; Disease-Free Survival; Family; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Incidence; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; T-Lymphocytes; Tacrolimus; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine

2006
Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention.
    Blood, 1994, Aug-15, Volume: 84, Issue:4

    Topics: Anemia, Aplastic; Bacteremia; Bacterial Infections; Bone Marrow Transplantation; Candidiasis; Female; Fungemia; Graft vs Host Disease; Histocompatibility Testing; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methylprednisolone; Myelodysplastic Syndromes; Regression Analysis; Risk Factors; Sepsis; Whole-Body Irradiation

1994
Cyclosporine combined with methylprednisolone or methotrexate in prophylaxis of moderate to severe acute graft-versus-host disease.
    Bone marrow transplantation, 1993, Volume: 12, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Incidence; Japan; Leukemia, Myeloid; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Severity of Illness Index

1993
Corticosteroid is not beneficial in multiple-drug combination chemotherapy for multiple myeloma. Finnish Leukaemia Group.
    European journal of haematology, 1993, Volume: 51, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Leukemia, Myeloid, Acute; Lomustine; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Rate; Vincristine

1993
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:1

    Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Infections; Karyotyping; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Prognosis; Recurrence; Regression Analysis; Survival Rate; Treatment Outcome; Whole-Body Irradiation

1996
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial.
    Blood, 1997, May-15, Volume: 89, Issue:10

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Infant; Infections; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Recurrence; Respiratory Insufficiency; Transplantation Conditioning; Treatment Outcome

1997

Other Studies

40 other study(ies) available for methylprednisolone and Dysmyelopoietic Syndromes

ArticleYear
Central nervous system graft-versus-host disease in a 68-year-old man presenting with myoclonus.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2019, Sep-30, Volume: 191, Issue:39

    Topics: Aged; Brain Diseases; Central Nervous System Diseases; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Large Granular Lymphocytic; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Myelodysplastic Syndromes; Myoclonus; Pulse Therapy, Drug; Transplantation, Homologous

2019
Sweet syndrome with pulmonary involvement in a patient with myelodysplastic syndrome.
    Dermatology online journal, 2020, Mar-15, Volume: 26, Issue:3

    Topics: Diagnosis, Differential; Female; Glucocorticoids; Histone-Lysine N-Methyltransferase; Humans; Lung; Lung Diseases; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Myeloid-Lymphoid Leukemia Protein; Pancytopenia; Sweet Syndrome; Tomography, X-Ray Computed

2020
Sweet syndrome secondary to myelodysplastic syndrome mimicking necrotizing fasciitis.
    Annals of hematology, 2017, Volume: 96, Issue:8

    Topics: Adult; Debridement; Delayed Diagnosis; Diagnostic Errors; Disease Progression; Fasciitis, Necrotizing; Humans; Karyotyping; Male; Methylprednisolone; Myelodysplastic Syndromes; Sweet Syndrome

2017
Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: A case report.
    Medicine, 2017, Volume: 96, Issue:50

    Topics: Antirheumatic Agents; Behcet Syndrome; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Pneumonia; Thalidomide

2017
A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation.
    International journal of hematology, 2019, Volume: 110, Issue:5

    Topics: Adult; Calcineurin Inhibitors; Central Nervous System; Chronic Disease; Female; Graft vs Host Disease; Humans; Methylprednisolone; Myelodysplastic Syndromes; Peripheral Blood Stem Cell Transplantation; Plasma Exchange; Transplantation, Homologous

2019
Cerebral toxoplasmosis after umbilical cord blood transplantation diagnosed by the detection of anti-toxoplasma specific IgM antibody in cerebrospinal fluid.
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:4

    Topics: Antibodies, Protozoan; Biomarkers; Clindamycin; Cord Blood Stem Cell Transplantation; Early Diagnosis; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Immunoglobulin M; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Tacrolimus; Toxoplasma; Toxoplasmosis, Cerebral; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination

2014
Sweet's Syndrome with Myelodysplasia.
    Indian journal of pediatrics, 2015, Volume: 82, Issue:6

    Topics: Adolescent; Diagnosis, Differential; Drug Administration Schedule; Exanthema; Fever; Glucocorticoids; Humans; Male; Methylprednisolone; Myelodysplastic Syndromes; Sweet Syndrome; Treatment Outcome

2015
Azacitidine-Induced Pericarditis: A Case Series.
    Pharmacotherapy, 2016, Volume: 36, Issue:4

    Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Chest Pain; Combined Modality Therapy; Diagnosis, Differential; DNA Modification Methylases; Drug Monitoring; Enzyme Inhibitors; Female; Glucocorticoids; Humans; Leukemia, Myeloid, Acute; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Pericarditis; Prednisone; Treatment Outcome

2016
Interstitial pneumonia associated with progression of myelodysplastic syndrome.
    International journal of hematology, 2009, Volume: 89, Issue:5

    Topics: Aged; Disease Progression; Female; Humans; Lung Diseases, Interstitial; Methylprednisolone; Myelodysplastic Syndromes; Steroids

2009
Successful treatment of MDS with lenalidomide, complicated by transient autoimmune hemolysis.
    Annals of hematology, 2010, Volume: 89, Issue:3

    Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Female; Humans; Immunoglobulins; Lenalidomide; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Thalidomide; Treatment Outcome

2010
Disappearing myelodysplastic syndrome-associated hemolytic anemia in leukemic transformation.
    International archives of allergy and immunology, 2010, Volume: 152, Issue:4

    Topics: Aged; Anemia, Hemolytic, Autoimmune; Autoimmunity; Cell Count; Cell Proliferation; Cell Transformation, Neoplastic; Glucocorticoids; Granulocyte Precursor Cells; Humans; Leukemia, Myeloid, Acute; Male; Methylprednisolone; Myelodysplastic Syndromes; Reticulocytes

2010
Easily missed extracutaneous manifestation of malignancy-associated Sweet's syndrome: systemic inflammatory response syndrome.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Aug-20, Volume: 29, Issue:24

    Topics: Aged; Fatal Outcome; Humans; Male; Methylprednisolone; Myelodysplastic Syndromes; Prednisone; Sweet Syndrome; Systemic Inflammatory Response Syndrome

2011
Neuro-Sweet disease mimicking recurrent anaplastic astrocytoma associated with therapy-related myelodysplastic syndrome: a case report.
    Clinical neurology and neurosurgery, 2012, Volume: 114, Issue:7

    Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Astrocytoma; Brain; Brain Neoplasms; Carcinoma; Chemoradiotherapy; Drug Eruptions; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Nimustine; Sweet Syndrome

2012
Painful oral aphthae and myositis.
    International journal of dermatology, 2012, Volume: 51, Issue:10

    Topics: Anti-Inflammatory Agents; C-Reactive Protein; Creatine Kinase; Humans; Leukemia; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Myositis; Pain; Pancytopenia; Stomatitis, Aphthous; Sweet Syndrome; Treatment Outcome

2012
Successful immunosuppressive therapy for a child with Myelodysplastic syndrome.
    Medical and pediatric oncology, 2003, Volume: 40, Issue:5

    Topics: Anemia, Refractory; Anti-Inflammatory Agents; Antilymphocyte Serum; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Methylprednisolone; Myelodysplastic Syndromes

2003
Steroid-induced tumor lysis syndrome in a patient with preleukemia.
    Clinical nephrology, 2003, Volume: 59, Issue:3

    Topics: Acute Kidney Injury; Adult; Glucocorticoids; Humans; Male; Methylprednisolone; Myelodysplastic Syndromes; Tumor Lysis Syndrome

2003
Prognostic value of cyclic GMP in patients undergoing allogeneic bone marrow transplantation after conditioning with total body irradiation.
    Bone marrow transplantation, 2003, Volume: 31, Issue:10

    Topics: Adolescent; Adult; Biomarkers; Blast Crisis; Bone Marrow Transplantation; Cyclic GMP; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Methylprednisolone; Monitoring, Physiologic; Myelodysplastic Syndromes; Neoplasm Staging; Nitric Oxide; Prognosis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation

2003
Immunosuppressive therapy for myelodysplastic syndrome: efficacy of methylprednisolone pulse therapy with or without cyclosporin A.
    Journal of cancer research and clinical oncology, 2003, Volume: 129, Issue:8

    Topics: Aged; Aged, 80 and over; Cyclosporine; Drug Therapy, Combination; Female; Hemoglobins; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Pulse Therapy, Drug; Survival Analysis; Treatment Outcome

2003
Successful treatment of pyoderma gangrenosum that developed in a patient with myelodysplastic syndrome.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2003, Volume: 9, Issue:3

    Topics: Diagnosis, Differential; Humans; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Neck; Pyoderma Gangrenosum; Skin Ulcer

2003
Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
    Journal of experimental & clinical cancer research : CR, 2004, Volume: 23, Issue:1

    Topics: Aged; Androgens; Anemia; Anemia, Refractory; Anti-Inflammatory Agents; Blood Transfusion; Bone Marrow Cells; Drug Therapy, Combination; Erythrocytes; Erythropoietin; Female; Humans; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Nandrolone; Recombinant Proteins; Time Factors

2004
[Successful corticosteroid treatment of thrombocytopenia in a pregnant woman with myelodysplastic syndrome (refractory anemia)].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2004, Volume: 45, Issue:5

    Topics: Adult; Anemia, Refractory; Female; Humans; Methylprednisolone; Myelodysplastic Syndromes; Pregnancy; Pregnancy Complications, Hematologic; Puerperal Disorders; Purpura, Thrombocytopenic, Idiopathic

2004
Myelodysplastic syndrome associated with multiple autoimmune disorders.
    Clinical rheumatology, 2005, Volume: 24, Issue:4

    Topics: Aged; Aged, 80 and over; Arthritis; Autoimmune Diseases; Blood Transfusion; Combined Modality Therapy; Dermatitis; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Filgrastim; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Male; Methylprednisolone; Myelodysplastic Syndromes; Recombinant Proteins; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vasculitis

2005
Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
    Pediatric blood & cancer, 2006, May-01, Volume: 46, Issue:5

    Topics: Adolescent; Adult; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Chronic Disease; Cyclophosphamide; Cyclosporine; Fanconi Anemia; Female; Fetal Blood; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Survival Rate; T-Lymphocytes; Treatment Outcome; Vidarabine

2006
Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy.
    Bone marrow transplantation, 2006, Volume: 38, Issue:4

    Topics: Acute Disease; Adult; Aged; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Male; Methylprednisolone; Middle Aged; Muscular Diseases; Myelodysplastic Syndromes; Retrospective Studies; Steroids

2006
Immune-mediated myelopathy following allogeneic stem cell transplantation.
    International journal of hematology, 2006, Volume: 84, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methylprednisolone; Myelodysplastic Syndromes; Pancytopenia; Spinal Cord Diseases; Stem Cell Transplantation; Transplantation Chimera; Transplantation, Homologous

2006
Selective blast cell reduction in elderly patients with acute myeloid leukemia secondary to myelodysplastic syndrome treated with methylprednisolone.
    International journal of hematology, 2007, Volume: 85, Issue:4

    Topics: Aged; Aged, 80 and over; Blast Crisis; Female; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Treatment Outcome

2007
Azacitidine-associated hyperthermia and interstitial pneumonitis in a patient with myelodysplastic syndrome.
    Pharmacotherapy, 2007, Volume: 27, Issue:12

    Topics: Antimetabolites, Antineoplastic; Azacitidine; Female; Fever; Glucocorticoids; Humans; Lung Diseases, Interstitial; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Probability; Respiratory Distress Syndrome

2007
[Differentiation therapy for myelodysplastic syndrome].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1993, Volume: 34, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Cell Differentiation; Cytarabine; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Podophyllotoxin

1993
Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia.
    Blood, 1995, May-01, Volume: 85, Issue:9

    Topics: Actuarial Analysis; Adolescent; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Cytarabine; Disease-Free Survival; Female; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Histocompatibility; Humans; Infections; Leukemia; Lung Diseases, Interstitial; Male; Methylprednisolone; Myelodysplastic Syndromes; Retrospective Studies; Risk Factors; Survival Analysis; Tissue Donors; Treatment Outcome; Whole-Body Irradiation; Wisconsin

1995
Evolution of severe aplastic anemia to myelodysplasia with monosomy 7 following granulocyte colony-stimulating factor, erythropoietin and high-dose methylprednisolone combination therapy.
    Internal medicine (Tokyo, Japan), 1995, Volume: 34, Issue:9

    Topics: Adult; Anemia, Aplastic; Chromosomes, Human, Pair 7; Drug Therapy, Combination; Erythropoietin; Glucocorticoids; Granulocyte Colony-Stimulating Factor; Humans; Male; Methylprednisolone; Monosomy; Myelodysplastic Syndromes

1995
Sustained trilineage recovery and disappearance of abnormal chromosome clone in a patient with myelodysplastic syndrome following combination therapy with cytokines (granulocyte colony-stimulating factor and erythropoietin) and high-dose methylprednisolon
    British journal of haematology, 1996, Volume: 93, Issue:1

    Topics: Anti-Inflammatory Agents; Chromosome Deletion; Cytokines; Drug Therapy, Combination; Erythropoietin; Granulocyte Colony-Stimulating Factor; Humans; Karyotyping; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes

1996
High-dose methylprednisolone, low-dose cytosine arabinoside, and mitoxantrone in children with myelodysplastic syndromes.
    Hematologic pathology, 1995, Volume: 9, Issue:3-4

    Topics: Adolescent; Child; Child, Preschool; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Methylprednisolone; Mitoxantrone; Myelodysplastic Syndromes

1995
Simultaneous occurrence of large B-cell non-Hodgkin lymphoma and myelodysplastic syndrome rapidly evolving into acute myeloblastic leukemia.
    Leukemia & lymphoma, 1996, Volume: 21, Issue:3-4

    Topics: Aged; Female; Humans; Leukemia, Myeloid, Acute; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Methylprednisolone; Myelodysplastic Syndromes

1996
Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicity.
    Bone marrow transplantation, 1997, Volume: 19, Issue:12

    Topics: Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Living Donors; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; T-Lymphocytes; Transplantation Conditioning

1997
Effect of short-course high-dose methylprednisolone treatment on serum IL-2 levels in children with myelodysplastic syndromes: a pilot study.
    Leukemia research, 1997, Volume: 21, Issue:8

    Topics: Adolescent; Child; Child, Preschool; Female; Humans; Interleukin-2; Lymphocyte Count; Male; Methylprednisolone; Myelodysplastic Syndromes; Pilot Projects

1997
Acute myeloid leukaemia with trilineage myelodysplasia complicated by masked diabetes insipidus.
    Clinical and laboratory haematology, 2000, Volume: 22, Issue:4

    Topics: Acute Disease; Aged; Arginine Vasopressin; Diabetes Insipidus; Glucocorticoids; Humans; Leukemia, Myeloid; Male; Methylprednisolone; Myelodysplastic Syndromes; Polyuria; Steroids

2000
Evaluation of children with myelodysplastic syndrome: importance of extramedullary disease as a presenting symptom.
    Leukemia & lymphoma, 2001, Volume: 42, Issue:4

    Topics: Adolescent; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Diagnosis, Differential; Female; Humans; Infant; Leukemia, Myelomonocytic, Chronic; Male; Methylprednisolone; Myelodysplastic Syndromes; Prospective Studies; Remission Induction; Sarcoma, Myeloid; Treatment Outcome

2001
An effective acute graft-vs.-host disease prophylaxis with minidose methotrexate, cyclosporine, and single-dose methylprednisolone.
    American journal of hematology, 1991, Volume: 38, Issue:4

    Topics: Bone Marrow Transplantation; Cyclosporine; Dose-Response Relationship, Drug; Graft vs Host Disease; Humans; Leukemia; Methotrexate; Methylprednisolone; Multiple Myeloma; Myelodysplastic Syndromes

1991
Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens.
    Experimental hematology, 1987, Volume: 15, Issue:3

    Topics: Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Dose-Response Relationship, Drug; Female; Humans; Immunosuppression Therapy; Methylprednisolone; Myelodysplastic Syndromes; Oxymetholone; T-Lymphocytes

1987
Pyoderma gangrenosum of the head and neck.
    The Laryngoscope, 1987, Volume: 97, Issue:7 Pt 1

    Topics: Adult; Hand Dermatoses; Head; Humans; Male; Methylprednisolone; Myelodysplastic Syndromes; Neck; Pyoderma; Skin Ulcer

1987